# Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

> **NCT01473251** · NA · COMPLETED · sponsor: **Vitreo-Retinal Associates, Michigan** · enrollment: 16 (actual)

## Conditions studied

- Exudative Macular Degeneration
- Diabetic Macular Edema

## Interventions

- **DRUG:** Avastin
- **DRUG:** Avastin
- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT01473251
- **Lead sponsor:** Vitreo-Retinal Associates, Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473251, "Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01473251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*